-
1
Autoimmune gastritis (AIG) is characterized by the immune-mediated destruction of gastric parietal cells, leading to vitamin B12 deficiency and increased malignancy risk.
-
2
Diagnosis of AIG involves endoscopic findings, serological markers, and histopathological confirmation, often complicated by serological variability.
-
3
AIG has a global prevalence of approximately 3.85%, with higher incidence in women and significant associations with other autoimmune diseases.
-
4
The management of AIG has shifted towards precision medicine, emphasizing individualized risk stratification and emerging immunomodulatory therapies.
-
5
Epidemiological variations in AIG prevalence reflect genetic and environmental factors, necessitating tailored diagnostic and management strategies.
